Cargando…

CyPass(®) Micro-Stent Safety and Efficacy at One Year: What Have We Learned?

PURPOSE: The suprachoroidal pathway can potentially provide a viable target for intraocular pressure (IOP) control. We present efficacy and safety result for the CyPass(®) Micro-Stent that provides insight into the use of the suprachoroidal space for IOP reduction. MATERIALS AND METHODS: A retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabbay, Itay E, Ruben, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221248/ https://www.ncbi.nlm.nih.gov/pubmed/32435122 http://dx.doi.org/10.5005/jp-journals-10078-1264

Ejemplares similares

Delayed bilateral hypertensive crisis with CyPass Micro-stent – The highs and lows
por: McCartney, Matthew, et al.
Publicado: (2020)

Ultrastructural analysis of explanted CyPass microstents and correlation with clinical findings
por: Hübner, Lisa, et al.
Publicado: (2022)

Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis
por: Mahdavi Fard, Ali, et al.
Publicado: (2019)

Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis
por: Mahdavi Fard, Ali, et al.
Publicado: (2019)

Management of Persistent Hypotony after Supraciliary CyPass(®) Implantation Using Argon Laser
por: Fernando, Del Valle-Nava, et al.
Publicado: (2019)

Letter to the editor: Comparing iStent versus CyPass with or without phacoemulsification in patients with glaucoma: a meta-analysis
por: Katz, L. Jay, et al.
Publicado: (2019)

Use of Nd:YAG laser to recanalize occluded Cypass Micro-Stent in the early post-operative period
por: Perez, Claudio I., et al.
Publicado: (2018)

The Quest for the Holy Grail of Glaucoma Surgery: Does Cypass Herald the End?
por: Bhartiya, Shibal, et al.
Publicado: (2018)

MicroRNAs and cancer: what we know and what we still have to learn
por: Calin, George A
Publicado: (2009)

One year after the COVID-19: What have we learnt, what shall we do next?
por: Gorwood, Philip, et al.
Publicado: (2021)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
por: Vieira, Jose Gilberto H.
Publicado: (2012)

Have We Passed the Peak? The COVID-19 Plastic Surgery Webinar Pandemic
por: Navia, Alfonso, et al.
Publicado: (2020)

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
por: Byrne, Robert A., et al.
Publicado: (2015)

Signal stability of Cy3 and Cy5 on antibody microarrays
por: Gu, Qiang, et al.
Publicado: (2006)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Shall We Have One Standard of Morals? What Shall the New Standard Be?
Publicado: (1913)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

Lipoabdominoplasty: What We Have Implemented and What We Have Modified over 26 Years
por: Cárdenas-Camarena, Lázaro, et al.
Publicado: (2023)

MicroRNA Mechanisms of Action: What have We Learned from Mice?
por: Jin, Hyun Yong, et al.
Publicado: (2015)

Population Equation: Balancing What We Need With What We Have
por: Dahl, Richard
Publicado: (2005)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

CyTOF(®) for the Masses
por: Iyer, Akshay, et al.
Publicado: (2022)

Otolaryngology During the COVID-19 Pandemic: What We Have Learned in Year One
por: Chandrasekhar, Sujana S.
Publicado: (2020)

COVID-19 Pandemic in Lebanon: One Year Later, What Have We Learnt?
por: Koweyes, Jad, et al.
Publicado: (2021)

USMLE Step-1 is Going to Pass/Fail, Now What Do We Do?
por: Belovich, Andrea N., et al.
Publicado: (2021)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

What Shall We Have for Breakfast?
Publicado: (1890)

SARS: What have we learned?
Publicado: (2003)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

Augmented Renal Clearance: What Have We Known and What Will We Do?
por: Luo, Yifan, et al.
Publicado: (2021)

A highly fluorescent DNA toolkit: synthesis and properties of oligonucleotides containing new Cy3, Cy5 and Cy3B monomers
por: Hall, Lucy M., et al.
Publicado: (2012)

CyDNA: Synthesis and Replication of Highly Cy-Dye Substituted DNA by an Evolved Polymerase
por: Ramsay, Nicola, et al.
Publicado: (2010)

Sequence-Dependent Fluorescence of Cy3- and Cy5-Labeled Double-Stranded DNA
por: Kretschy, Nicole, et al.
Publicado: (2016)

A review of the iStent(®) trabecular micro-bypass stent: safety and efficacy
por: Wellik, Sarah R, et al.
Publicado: (2015)

INDIAN PSYCHIATRY AT THE CROSSROADS - WHAT WE CAN DO WITH WHAT WE HAVE?1
por: Channabasavanna, S.M.
Publicado: (1992)

Erratum: asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

Hospitals and the Doctrine of "Cy-Pres"
Publicado: (1910)

Cannot write session to /tmp/vufind_sessions/sess_88aahnv5cd91302r6tn1egpq49